2-201209067-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032977.4(CASP10):​c.923-3C>T variant causes a splice region, intron change. The variant allele was found at a frequency of 0.0123 in 1,372,936 control chromosomes in the GnomAD database, including 1,590 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.064 ( 854 hom., cov: 29)
Exomes 𝑓: 0.0065 ( 736 hom. )

Consequence

CASP10
NM_032977.4 splice_region, intron

Scores

2
Splicing: ADA: 0.001292
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.70

Publications

7 publications found
Variant links:
Genes affected
CASP10 (HGNC:1500): (caspase 10) This gene encodes a protein which is a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein cleaves and activates caspases 3 and 7, and the protein itself is processed by caspase 8. Mutations in this gene are associated with type IIA autoimmune lymphoproliferative syndrome, non-Hodgkin lymphoma and gastric cancer. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CASP10 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2A
    Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autoimmune lymphoproliferative syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 2-201209067-C-T is Benign according to our data. Variant chr2-201209067-C-T is described in ClinVar as [Benign]. Clinvar id is 333434.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP10NM_032977.4 linkc.923-3C>T splice_region_variant, intron_variant Intron 8 of 9 ENST00000286186.11 NP_116759.2 Q92851-4A0A0S2Z3Z5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP10ENST00000286186.11 linkc.923-3C>T splice_region_variant, intron_variant Intron 8 of 9 1 NM_032977.4 ENSP00000286186.6 Q92851-4

Frequencies

GnomAD3 genomes
AF:
0.0642
AC:
8754
AN:
136290
Hom.:
852
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.219
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0277
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00725
Gnomad NFE
AF:
0.000847
Gnomad OTH
AF:
0.0495
GnomAD2 exomes
AF:
0.0163
AC:
3610
AN:
221166
AF XY:
0.0123
show subpopulations
Gnomad AFR exome
AF:
0.211
Gnomad AMR exome
AF:
0.0100
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000563
Gnomad OTH exome
AF:
0.00836
GnomAD4 exome
AF:
0.00650
AC:
8043
AN:
1236566
Hom.:
736
Cov.:
34
AF XY:
0.00564
AC XY:
3506
AN XY:
621934
show subpopulations
African (AFR)
AF:
0.217
AC:
6361
AN:
29294
American (AMR)
AF:
0.0118
AC:
454
AN:
38612
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36782
South Asian (SAS)
AF:
0.000677
AC:
53
AN:
78332
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49498
Middle Eastern (MID)
AF:
0.0117
AC:
45
AN:
3852
European-Non Finnish (NFE)
AF:
0.000390
AC:
361
AN:
925254
Other (OTH)
AF:
0.0148
AC:
769
AN:
51826
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
272
544
815
1087
1359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0644
AC:
8776
AN:
136370
Hom.:
854
Cov.:
29
AF XY:
0.0639
AC XY:
4153
AN XY:
65006
show subpopulations
African (AFR)
AF:
0.219
AC:
8272
AN:
37714
American (AMR)
AF:
0.0276
AC:
349
AN:
12638
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3320
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4518
South Asian (SAS)
AF:
0.00166
AC:
7
AN:
4220
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7244
Middle Eastern (MID)
AF:
0.00781
AC:
2
AN:
256
European-Non Finnish (NFE)
AF:
0.000847
AC:
54
AN:
63722
Other (OTH)
AF:
0.0490
AC:
92
AN:
1878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
322
643
965
1286
1608
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0228
Hom.:
370
Bravo
AF:
0.0681

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoimmune lymphoproliferative syndrome type 2A Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
4.9
DANN
Benign
0.62
PhyloP100
3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.048
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6753900; hg19: chr2-202073790; API